Testing a bedside blood clot test in children
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial checks whether a bedside machine (TEG 6s) can measure blood clotting in children during planned surgery. It may help doctors get faster, more accurate information about clotting during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be under 18 years old and having an elective surgery at Riley Hospital for Children
- Have surgery planned in the operating room
- Do not have a known blood clotting disorder
- Do not receive medicines that can change blood clotting
- Not be in foster care or a ward of the court
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special blood test called TEG can help doctors manage bleeding during major surgeries in children. It may help reduce the need for blood transfusions by guiding treatment more precisely.
This study is testing a new device, called Quantra, that checks how well your child's blood clots during surgery. By comparing its results to standard lab tests in healthy children, researchers hope to confirm it is accurate and useful for guiding treatment in kids.
This trial tests whether a special blood clotting test called thromboelastography can help assess clotting problems after a head injury. It may help doctors better understand bleeding risk and related complications early after trauma.
This study looks at a special blood test (called thromboelastography) that checks how well your blood clots. The goal is to see if this test can predict how the surgery goes and whether you might get a blood clot after surgery. If you join, the test will be done before and after your brain surgery, and you will be monitored for any blood clot complications.
This study looks at how cancer and surgery affect blood clotting. It may help doctors understand and prevent blood clots in patients having surgery for certain cancers.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
Hear when a new Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.